United States · Platforms & data · The Motley Fool

The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power?

Published by The Motley Fool · United States 1 h ago

Detailed summary

PJP delivered 32.8% returns over one year with concentrated U.S. pharma exposure, while IXJ offers broader global healthcare diversification and a higher dividend yield.

Read the full article on The Motley Fool Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.fool.com)

Also worth reading

MarketWatch

How much in Roth conversions can you do in 2027 with the new tax brackets?

CNBC

Berkshire Hathaway more than doubles buybacks in third quarter as earnings decline

Investing.com

Heavy rain floods tents housing Gaza displaced people, aid shortages hamper response

Benzinga

Best Stocks Under $5

TheStreet

Fed rate call leaves stock investors watching December closely

TipRanks